Report cover image

Tree Nut Allergy Market (Type: Walnut, Almond, Hazelnut, Pecan, Cashew, Pistachio, and Others; Treatment: Antihistamines, Epinephrine, and Others) - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Publisher Transparency Market Research Pvt. Ltd.
Published May 30, 2022
Length 105 Pages
SKU # TNPR17326566

Description

Tree Nut Allergy Market (Type: Walnut, Almond, Hazelnut, Pecan, Cashew, Pistachio, and Others; Treatment: Antihistamines, Epinephrine, and Others) - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Companies Mentioned

Bayer AG
Teva Pharmaceuticals USA, Inc.
Pfizer, Inc.
Amphastar Pharmaceuticals, Inc.
Amneal Pharmaceuticals LLC.
Kaleo, Inc.

Countries

U.S

Forecast Year (first) - 2022

Forecast Year (last) - 2031

Forecast Year ( first)  Value - 233.7

Forecast Year (last) Value - 433.2

CAGR % - 0.065

Currency - US$ Mn

Table of Contents

105 Pages
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: U.S. Tree Nut Allergy Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. U.S. Tree Nut Allergy Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Overview of Tree Nut Allergy: Components, Proteins responsible for allergy
5.2. Insights on Food Allergies
5.3. Allergy Prevalence Data & Co-allergies Incidence Data in U.S
5.4. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.5. COVID-19 Pandemic Impact on Industry
6. U.S. Tree Nut Allergy Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017–2031
6.3.1. Cashews
6.3.2. Pistachios
6.3.3. Almonds
6.3.4. Hazelnuts
6.3.5. Pecans
6.3.6. Walnuts
6.3.7. Others
6.4. Market Attractiveness Analysis, by Type
7. U.S. Tree Nut Allergy Market Analysis and Forecast, by Treatment
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Treatment, 2017–2031
7.3.1. Antihistamines
7.3.2. Epinephrine
7.3.3. Others
7.4. Market Attractiveness Analysis, by Treatment
8. U.S. Tree Nut Allergy Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Distribution Channel, 2017–2031
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Market Attractiveness Analysis, by Distribution Channel
9. Competition Landscape
9.1. Market Player - Competition Matrix (by tier and size of companies)
9.2. Company Profiles
9.2.1. Bayer AG
9.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.1.2. Product Portfolio
9.2.1.3. Financial Overview
9.2.1.4. SWOT Analysis
9.2.1.5. Strategic Overview
9.2.2. Teva Pharmaceuticals USA, Inc.
9.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.2.2. Product Portfolio
9.2.2.3. Financial Overview
9.2.2.4. SWOT Analysis
9.2.2.5. Strategic Overview
9.2.3. Pfizer, Inc.
9.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.3.2. Product Portfolio
9.2.3.3. Financial Overview
9.2.3.4. SWOT Analysis
9.2.3.5. Strategic Overview
9.2.4. Amphastar Pharmaceuticals, Inc.
9.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.4.2. Product Portfolio
9.2.4.3. Financial Overview
9.2.4.4. SWOT Analysis
9.2.4.5. Strategic Overview
9.2.5. Amneal Pharmaceuticals LLC.
9.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.5.2. Product Portfolio
9.2.5.3. Financial Overview
9.2.5.4. SWOT Analysis
9.2.5.5. Strategic Overview
9.2.6. Kaleo, Inc.
9.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.6.2. Product Portfolio
9.2.6.3. Financial Overview
9.2.6.4. SWOT Analysis
9.2.6.5. Strategic Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us